YANKCOM Partnership’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
YANKCOM Partnership's AMGN Position: Q2 2026 in Review
YANKCOM Partnership reduced its Amgen (AMGN) stake by 2.5% in Q2 2026, selling an estimated $12K and leaving 1,341 shares worth $486K. The position accounts for 0.17% of the portfolio, ranked #99.
YANKCOM Partnership first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 1,998 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- YANKCOM Partnership held 1,341 shares of Amgen worth $486K as of Q2 2026.
- YANKCOM Partnership sold 35 Amgen shares in Q2 2026, an estimated $12K.
- Amgen made up 0.17% of YANKCOM Partnership's portfolio in Q2 2026, its #99 holding.
- YANKCOM Partnership first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 1,998 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on YANKCOM Partnership's 13F filing for Q2 2026, filed 21 Jul 2026.